Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

Investigating GLP-1 RAs reveals their impact on women's health, addressing metabolic disorders, reproductive health, and ...

The identification of BRP, an anti-obesity peptide, showcases the transformative role of AI in drug discovery and its ...

FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...

Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

OPKO Health (OPK) and Entera Bio (ENTX), a leader in the development of oral peptides and proteins replacement therapies, entered into a ...

It’s the strawberry that made the internet go bananas. In late February, influencer Alyssa Antoci — whose family owns luxury Los Angeles grocer Erewhon — posted a TikTok about a rather pricy ...

The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...

The Fate series is an incredibly popular and beloved anime. From the outside, it's often regarded as one of the more complex series to watch. There are dozens of spinoff series featuring the Fate ...

This week’s Deadline: Legal Newsletter looks at a looming decision from the Supreme Court on Trump's freezing of congressionally approved spending, plus other legal news. By Jordan Rubin Welcome ...

Ukrainian President Volodymyr Zelensky speaks during an interview with Fox News Chief Political Anchor Bret Baier. Photo by Win McNamee/Getty Images Ukrainian President Volodymyr Zelensky, in his ...